The author used ear acupuncture to treat 52 cases with reaction to blood transfu-sion or fluid infusion and obtained a good and quick therapeutic effect, 50 cases (96. 2％) were curedand 2 cases (3. 8％) improved.
Objectives Bone-marrow stem-cell transplantation has been shown to improve cardiac function in patients with acute myocardial infarction (AMI) , but the safety of intracoronory infusion of autologous peripheral blood ...Objectives Bone-marrow stem-cell transplantation has been shown to improve cardiac function in patients with acute myocardial infarction (AMI) , but the safety of intracoronory infusion of autologous peripheral blood stem-cell (PBSCs) in patients with AMI is unknown. For this reason, we observe the feasibility and safety of PBSCs transplantation by intracoronory infusion in such patients. Methods 41 patients with AMI were allocated to receive granulocyte colony-stimulating factor (G- CSF: Filgrastim,300μg) with the dose of 300μg~ 600μg/day to mobilize the stem cell, and the duration of applying G-CSF was 5 days. On the sixth day, PBSCs were separated by Baxter CS 3000 blood cel 1 separator into suspend liquid 57 ml. Then the suspend liquid was infused into the infarct related artery (IRA) by occluding the over the wire balloon and infusing artery through balloon center lumen. In the process of the intracoronary infusion of PBSCs, the complications should be observed, which were arrhythmias including of bradycardia, sinus arrest or atrial ventricular block, premature ve. ntricular beats ,ven~icular tachycardia, ventricular fibrillation; and hypotention, etc. Results There were total 10 cases with complications during the intracoronary infusion of PBSCs. The incidence of complications was 24.4% (10/41), including bradyca- rdia was 2.4 % (1/41), sinus arrest or atrial ventri- cular block was 4.0% (2/41), ventricular fibrillation was 2.4 % (1/41), hypotention was 14.6 % (6/41). Conclusions In patients with AMI, intracoronary infusion of PBSCs is feasible and safe.展开更多
This paper reviews management of obstetric anaemia and the role of intravenous iron for the treatment of obstetric anaemia.Red blood cell transfusions are routinely used for haemoglobin restoration in anaemic women.Th...This paper reviews management of obstetric anaemia and the role of intravenous iron for the treatment of obstetric anaemia.Red blood cell transfusions are routinely used for haemoglobin restoration in anaemic women.The decision for red blood cell transfusion is made on a combination of haemoglobin level and clinical status,and it is suggested that transfusions are not necessary in those who are well compensated or when alternative therapy is available.To reduce the risk,intravenous iron infusion is proposed as a bloodless therapeutic approach.There are a variety of iron preparations.Intravenous iron infusion can reduce the requirement for blood transfusion in hemodynamically stable women with perinatal anaemia,especially in resource-scarce settings.It a cost-effective bloodless approach for the treatment of anaemia than can enhance patient outcomes.According to the literature,when haemoglobin is greater than 90 g/L,blood transfusion is not often required.In perinatal women with anaemia,the decision whether to administer blood or iron is based on patient preferences,haemoglobin levels,clinical symptoms,past and present medical conditions and the clinician’s judgement.Nevertheless,due to the lack of rigid criteria for blood transfusions in the majority of clinical settings,it is considered the default treatment for anaemia in perinatal women.展开更多
目的分析输血次数与多次输血血液病患者输注效果的关系。方法选取2020年5月—2023年7月菏泽市立医院收治的600例多次输血(≥2次)的血液病患者作为研究对象,根据输血次数不同将患者分为A组225例(2~3次)、B组195例(4~6次)及C组180例(≥7次...目的分析输血次数与多次输血血液病患者输注效果的关系。方法选取2020年5月—2023年7月菏泽市立医院收治的600例多次输血(≥2次)的血液病患者作为研究对象,根据输血次数不同将患者分为A组225例(2~3次)、B组195例(4~6次)及C组180例(≥7次)。比较3组患者血小板抗体阳性率;比较血小板抗体阳性与阴性患者输注血小板后1、24 h校正血小板计数增加值(CCI)及输注有效率。结果600例患者中共226例患者检测血小板抗体阳性,阳性率为37.67%,其中C组血小板抗体阳性率高于A、B组(P<0.01)。血小板抗体阳性者输注后1、24 h CCI及输注有效率均低于血小板阴性患者(P<0.01)。结论输血次数越多,血液病患者血小板抗体阳性率越高,而血小板抗体阳性患者的血小板输注效果较差,而血小板抗体筛查能有效提高输血效果。展开更多
文摘The author used ear acupuncture to treat 52 cases with reaction to blood transfu-sion or fluid infusion and obtained a good and quick therapeutic effect, 50 cases (96. 2％) were curedand 2 cases (3. 8％) improved.
文摘Objectives Bone-marrow stem-cell transplantation has been shown to improve cardiac function in patients with acute myocardial infarction (AMI) , but the safety of intracoronory infusion of autologous peripheral blood stem-cell (PBSCs) in patients with AMI is unknown. For this reason, we observe the feasibility and safety of PBSCs transplantation by intracoronory infusion in such patients. Methods 41 patients with AMI were allocated to receive granulocyte colony-stimulating factor (G- CSF: Filgrastim,300μg) with the dose of 300μg~ 600μg/day to mobilize the stem cell, and the duration of applying G-CSF was 5 days. On the sixth day, PBSCs were separated by Baxter CS 3000 blood cel 1 separator into suspend liquid 57 ml. Then the suspend liquid was infused into the infarct related artery (IRA) by occluding the over the wire balloon and infusing artery through balloon center lumen. In the process of the intracoronary infusion of PBSCs, the complications should be observed, which were arrhythmias including of bradycardia, sinus arrest or atrial ventricular block, premature ve. ntricular beats ,ven~icular tachycardia, ventricular fibrillation; and hypotention, etc. Results There were total 10 cases with complications during the intracoronary infusion of PBSCs. The incidence of complications was 24.4% (10/41), including bradyca- rdia was 2.4 % (1/41), sinus arrest or atrial ventri- cular block was 4.0% (2/41), ventricular fibrillation was 2.4 % (1/41), hypotention was 14.6 % (6/41). Conclusions In patients with AMI, intracoronary infusion of PBSCs is feasible and safe.
文摘This paper reviews management of obstetric anaemia and the role of intravenous iron for the treatment of obstetric anaemia.Red blood cell transfusions are routinely used for haemoglobin restoration in anaemic women.The decision for red blood cell transfusion is made on a combination of haemoglobin level and clinical status,and it is suggested that transfusions are not necessary in those who are well compensated or when alternative therapy is available.To reduce the risk,intravenous iron infusion is proposed as a bloodless therapeutic approach.There are a variety of iron preparations.Intravenous iron infusion can reduce the requirement for blood transfusion in hemodynamically stable women with perinatal anaemia,especially in resource-scarce settings.It a cost-effective bloodless approach for the treatment of anaemia than can enhance patient outcomes.According to the literature,when haemoglobin is greater than 90 g/L,blood transfusion is not often required.In perinatal women with anaemia,the decision whether to administer blood or iron is based on patient preferences,haemoglobin levels,clinical symptoms,past and present medical conditions and the clinician’s judgement.Nevertheless,due to the lack of rigid criteria for blood transfusions in the majority of clinical settings,it is considered the default treatment for anaemia in perinatal women.
文摘目的分析输血次数与多次输血血液病患者输注效果的关系。方法选取2020年5月—2023年7月菏泽市立医院收治的600例多次输血(≥2次)的血液病患者作为研究对象,根据输血次数不同将患者分为A组225例(2~3次)、B组195例(4~6次)及C组180例(≥7次)。比较3组患者血小板抗体阳性率;比较血小板抗体阳性与阴性患者输注血小板后1、24 h校正血小板计数增加值(CCI)及输注有效率。结果600例患者中共226例患者检测血小板抗体阳性,阳性率为37.67%,其中C组血小板抗体阳性率高于A、B组(P<0.01)。血小板抗体阳性者输注后1、24 h CCI及输注有效率均低于血小板阴性患者(P<0.01)。结论输血次数越多,血液病患者血小板抗体阳性率越高,而血小板抗体阳性患者的血小板输注效果较差,而血小板抗体筛查能有效提高输血效果。
